{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal&page=58", "query": { "condition": "Renal", "page": 58 }, "page_size": 10 }, "pagination": { "page": 58, "page_size": 10, "total_count": 6440, "total_pages": 644, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal&page=59&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Renal&page=57&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T21:49:04.236Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02009449", "title": "A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma", "Prostate Cancer", "Ovarian Cancer", "Renal Cell Carcinoma", "Colorectal Carcinoma", "Pancreatic Carcinoma", "Non-small Cell Lung Carcinoma", "Solid Tumors", "Breast Cancer" ], "interventions": [ { "name": "Pegilodecakin", "type": "DRUG" }, { "name": "Paclitaxel or Docetaxel and Carboplatin or Cisplatin", "type": "DRUG" }, { "name": "FOLFOX (Oxaliplatin/Leucovorin/5-Fluorouracil)", "type": "DRUG" }, { "name": "gemcitabine/nab-paclitaxel", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Pazopanib", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "nivolumab", "type": "DRUG" }, { "name": "Gemcitabine/carboplatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 353, "start_date": "2013-11-15", "completion_date": "2023-07-22", "has_results": true, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Denver, Colorado + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02009449" }, { "nct_id": "NCT00514306", "title": "Study of Intermittent OSI-906 Dosing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "OSI-906", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 79, "start_date": "2007-07-05", "completion_date": "2010-09-20", "has_results": false, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00514306" }, { "nct_id": "NCT01066949", "title": "Behavioral Intervention and Adherence in Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Behavioral self mangement", "type": "BEHAVIORAL" }, { "name": "Support and discussion", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2006-06", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2015-05-27", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 2, "location_summary": "Dubuque, Iowa • Iowa City, Iowa", "locations": [ { "city": "Dubuque", "state": "Iowa" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01066949" }, { "nct_id": "NCT02363972", "title": "Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease", "AV Fistula", "Fistula", "End Stage Kidney Disease" ], "interventions": [ { "name": "Ellipsys Vascular Access Catheter", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Endovascular", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 103, "start_date": "2015-02-10", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 5, "location_summary": "Tempe, Arizona • San Diego, California • Plano, Texas + 2 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Plano", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "North Chesterfield", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02363972" }, { "nct_id": "NCT00436657", "title": "Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Peritoneal Neoplasms", "Retroperitoneal Neoplasms", "Gastrointestinal Neoplasms", "Adenocarcinoma", "Neuroblastoma", "Ovarian Neoplasms", "Sarcoma", "Adrenocortical Carcinoma", "Wilms Tumor", "Rhabdomyosarcoma", "Desmoplastic Small Round Cell Tumor" ], "interventions": [ { "name": "CHPP of Cisplatin", "type": "DRUG" }, { "name": "Abdominal Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Years to 18 Years" }, "enrollment_count": 10, "start_date": "2007-02", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2012-04-02", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00436657" }, { "nct_id": "NCT01113801", "title": "A Study in Participants With Diabetic Kidney Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Kidney Disease", "Diabetic Nephropathy", "Diabetic Glomerulosclerosis" ], "interventions": [ { "name": "LY2382770", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 417, "start_date": "2010-07", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2019-09-17", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Inglewood, California • Los Angeles, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Inglewood", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01113801" }, { "nct_id": "NCT06110130", "title": "Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Kidney Diseases" ], "interventions": [ { "name": "Empagliflozin 10 MG", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington D.C. Veterans Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "19 Years to 90 Years" }, "enrollment_count": 60, "start_date": "2024-02-02", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06110130" }, { "nct_id": "NCT00456365", "title": "Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Polycystic Kidney, Autosomal Dominant" ], "interventions": [ { "name": "pravastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "22 Years", "sex": "ALL", "summary": "8 Years to 22 Years" }, "enrollment_count": 110, "start_date": "2006-11", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2018-03-09", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00456365" }, { "nct_id": "NCT04329767", "title": "A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Kidney Cancer" ], "interventions": [ { "name": "IRIS 1.0", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Intuitive Surgical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 122, "start_date": "2020-09-18", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2023-09-29", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 2, "location_summary": "Edison, New Jersey • Rochester, New York", "locations": [ { "city": "Edison", "state": "New Jersey" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04329767" }, { "nct_id": "NCT06966258", "title": "Inspire HER: Inspiring the Heart and Emotions for Radical Health", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular-kidney-metabolic Syndrome", "Cardiovascular Diseases", "Hypertension", "Diabetes", "Hyperlipidemia", "Kidney Disease", "Obesity", "Smoking" ], "interventions": [ { "name": "Inspire HER Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "79 Years", "sex": "FEMALE", "summary": "30 Years to 79 Years · Female only" }, "enrollment_count": 90, "start_date": "2025-11-15", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2025-12-29", "last_synced_at": "2026-10-30T21:49:04.236Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06966258" } ] }